Delivery Order SPE2DB20D3103-SPE2DB22FL6L5
- Not listed
- This federal contract award is for the delivery of pharmaceutical products, primarily Jardiance 10 mg tablets, to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,896.70, was awarded on July 18, 2022 and has a completion date of July 19, 2022. This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by...
- This federal contract award is for the delivery of pharmaceutical products, specifically Jardiance 25 mg tablets, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $17,470.92 and a completion date of February 19, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen...
- This federal contract award is for the delivery of pharmaceutical products, specifically Jardiance 10 mg tablets, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a total ceiling value of $3,983.95. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which is valued at $999,999,999 and...
- This federal contract award is for the delivery of pharmaceutical products, primarily Jardiance 25 mg tablets, to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,496.01 and an ultimate completion date of January 12, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of pharmaceutical products, specifically Jardiance 10 mg tablets, to the Defense Logistics Agency (DLA). The contract, valued at $21,800.30, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
- This federal contract award is for the delivery of pharmaceutical products, specifically the medication Jardiance 10 mg tablet, by Amerisourcebergen Drug Corp to the Defense Logistics Agency (DLA). The contract has a ceiling value of $18,695.84 and a period of performance through May 7, 2025. It is a firm-fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- This federal contract award is for the delivery of 4,563,195,295 units of the pharmaceutical product Jardiance 10 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $7,035.02 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor. This delivery order contract has an ultimate completion date of December 29, 2023, and was awarded on December 28, 2023....
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Jardiance 25 mg tablets. The $12,835.82 firm fixed-price delivery order contract has an ultimate completion date of February 2, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Jardiance 25 mg tablets. The contract has a ceiling value of $4,010.39 and a completion date of February 20, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award is for pharmaceutical products, specifically Jardiance 25 mg tablets, with a ceiling value of $19,434.63. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order and has a firm fixed price pricing type, with a final completion date of February 21, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FL6L5Delivery Order
This federal contract award is for the delivery of pharmaceutical products, primarily focused on the drug Jardiance 25 mg tablet, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,646.91 and an ultimate completion date of November 15, 2021. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 11/12/21 |